Outcomes Rocket

Pharma portfolios can create powerful opportunities, but without clear positioning, brands can end up competing with each other. In this episode, Lumanity’s Jakub Kaczor, VP, Strategy Consulting, and Peter Smith, SVP, Strategy Consulting, discuss the complexities of portfolio positioning in the pharmaceutical industry. The guests explain that while a focused R&D strategy drives commercial growth a...

In an AI-driven market, technology may be easier to replicate, but the right people remain a true competitive advantage. In this episode, Mike Silverstein, Managing Partner of Healthcare IT and Life Sciences at Direct Recruiters, discusses what healthcare companies often get wrong when building their teams. He explains why leaders should value grit over impressive résumés, how passive candidates c...

Medical technology is moving quickly, and the companies that succeed will be the ones that stay connected, think strategically, and solve the right problems. In this live episode from DeviceTalks Boston, Etienne Nichols, MedTech Guru at Greenlight Guru and host of the Global Medical Device Podcast, discusses the major shifts shaping the medical device industry. He shares insights on global regulat...

Healthcare robotics is not just about replacing tasks; it is about helping people do safer, more meaningful work. In this episode, Spencer Krause, President and CEO of SKA Robotics, shares how his team applies robotics across industries like mining, construction, agriculture, and healthcare. He explains how robotics can support hospitals by handling repetitive or difficult work, from moving waste...

Neurology care is in high demand, but long waitlists and specialist shortages continue to delay access for millions of patients. In this episode, Elizabeth Burstein, CEO and Co-founder of Neura Health, shares how her personal experience with delayed neurological care inspired a more accessible, technology-enabled care model. She explains how Neura Health supports patients with chronic neurological...

MedTech companies invest heavily in acquiring customers, but many still lack a clear strategy for retaining, expanding, and learning from them. Fortunately,  SaaS and tech already solved this years ago through the creation of a commercial function called Customer Success. In this episode, Rupal Ayer, Senior Director of Customer Success at Solventum, discusses why Customer Success should become a f...

Many patients with tremor are caught between medications that lose effectiveness and invasive procedures they may not be ready to pursue. In this episode, Deanna Harshbarger, CEO of Cala Health, discusses how non-invasive bioelectronic medicine is creating a new treatment pathway for patients with essential tremor. She explains how Cala’s wearable therapy measures each patient’s tremor, personaliz...

Orthopedic procedures are increasingly moving to ambulatory surgery centers, but many navigation technologies remain too expensive, complex, or inefficient for that setting. In this episode, Nic Aldrich, Vice President of Marketing at OrthAlign, discusses how handheld navigation technology is making precision orthopedic care more accessible. He explains how OrthAlign helps surgeons reduce variabil...

AI in medtech is most valuable when it supports better clinical decisions, not when it replaces clinicians. In this episode, Alexis Anderson speaks with Will Mauldin, Co-Founder and CEO of Rivanna Medical, live from DeviceTalks Boston. Will explains how Rivanna is bringing AI-enabled imaging to clinical settings where providers have traditionally relied on blind or manual procedures, beginning wit...

Lung cancer biopsies are still being done blind more often than you’d think, leading to costly diagnostic errors. In this episode, Reza Khorasaninejad, Founder & CEO at LEADOPTIK, discusses how advances in photonics and metasurface engineering are enabling highly miniaturized imaging systems for minimally invasive procedures. These innovations aim to address a major challenge in lung cancer biopsi...

Healthcare technology only matters when it makes care safer, more accessible, and easier to deliver at scale. In this episode, Adam McMullin, CEO of AvaSure, joins Saul to discuss how virtual care, ambient AI, and smart room platforms are transforming inpatient care. He explains how AvaSure creates a “cocoon of safety” around patients and care teams through capabilities such as fall prevention, vi...

MedTech innovation succeeds when bold ideas are matched with disciplined execution, strong teams, and a clear purpose. In this episode, James Corbett, transformational MedTech CEO and Board Advisor, joins Saul to share the leadership lessons, operating principles, and industry changes that have shaped his decades-long career. Drawing on experience leading companies including Boston Scientific, ev3...

The future of market access belongs to organizations that plan years in advance. In this episode, Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity, explains why pharmaceutical companies must prepare now for major market access changes coming in Europe and beyond. He highlights that Joint Clinical Assessments for rare disease assets, beginning in 2028, will require earlier pla...

AI is transforming medical robotics, but not in the ways many people expect. In this episode, KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics, discuss how labor shortages, increasing quality demands, and growing interest in AI are shaping the future of medical robotics. While AI is becoming more prevalent in areas such as simulation,...

A non-invasive Alzheimer’s therapy is moving closer to patients, and it could reshape how brain health is treated. In this episode, Christian Howell, CEO of Cognito Therapeutics, joins Saul live at DeviceTalks Boston to discuss how the company is advancing a novel Alzheimer’s therapy that uses sensory stimulation through light, sound, and touch. He shares insights from Cognito’s HOPE study, the la...

Health economics is not just about reimbursement. It is about proving how a technology reduces the total cost of care. In this episode, Betty Tsai, President of Cardiology Services International, explains why medtech companies must think beyond existing CPT or MS-DRG codes when shaping their commercialization strategies. Speaking with Saul at the MedTech Innovator event, she highlights how health...

What started as a one-year break from surgery became a global medtech movement. In this episode, Dr. Dylan Attard, CEO and Co-founder of MedTech World, shares how his journey from surgical training to entrepreneurship led to the creation of MedTech World, now a global platform hosting events across Europe, Asia, the Middle East, and North America. What began as a single event in Malta has evolved...

Most pharma launch frameworks don’t fail because they lack structure; they fail because they become rigid checklists that kill strategic thinking. In this episode, Lumanity’s Business Development Director, Jeff Hart, and Launch Excellence Principal, Kirsty Tait, talk about how pharmaceutical companies can scale launch excellence as pipelines grow and complexity increases. Kirsty and Jeff explain t...

What if the biggest barrier to better healthcare outcomes is… the blood draw itself? In this episode, Web Golinkin, President at Babson Diagnostics, discusses how his company is reinventing blood testing with a patient-friendly, fingertip-based system. He explains why traditional venipuncture drives anxiety and non-adherence, and how BetterWay improves both experience and outcomes. He also shares...

Great medtech innovations win because patients actually use them. In this episode, Ken Nelson, Partner and Founder at Nelson Jennings Ventures, shares his journey from cardiac device sales at Boston Scientific to helping commercialize major players in cardiac monitoring, including iRhythm, BioTelemetry, and Bardy Diagnostics. He highlights how innovations such as wearable cardiac patches have tran...

Simplifying the complex world of healthcare reimbursement. In this episode, Jason Considine, President of Experian Health, discusses shifting the industry's focus from denial management to denial prevention by leveraging AI at the point of registration. He discusses the implementation of the Patient Access Curator, a tool that automates insurance discovery and validation to reduce human error and...

AI is advancing rapidly in healthcare, but speed without governance can create serious clinical, legal, and enterprise-level risks. In this episode, Peter Bonis, MD, Chief Medical Officer at Wolters Kluwer Health, explores how his team is developing reliable, evidence-based AI tools to support frontline clinicians without compromising trust or safety. He explains why clinicians are adopting AI fas...

Most medtech startups fail before market. The ones that succeed? They plan for it from day one. In this episode, Amanda Helgeson, Business Development Manager at Forj Medical, discusses her work at the CDMO, which helps medtech startups navigate the critical transition from development to manufacturing. She notes that standout companies at Medtech Innovator pair meaningful clinical innovation with...

Healthcare payments are often discussed as a transparency problem, but the deeper issue is structural fragmentation across contracts, claims, remittances, and workflows. In this episode, Ted Ferrin, Senior Vice President of Payments Innovation at Zelis, explains how the acquisition of Rivet is bringing provider-facing payment intelligence into Zelis’s broader infrastructure. He discusses why achie...

Healthcare is drowning in documentation and fragmented data, but what if the system worked for clinicians rather than against them? In this episode, Dr. Richa Gupta, Vice President of Care Transformation at Ambience Healthcare, explains how Ambience provides a layer of intelligence on top of electronic medical records to optimize clinician workflow and patient interactions. Ambience’s ambient list...